Ipique
Country: European Union
Language: Portuguese
Source: EMA (European Medicines Agency)
Public Assessment Report
(PAR)
24-05-2022
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
bevacizumab
Available from:
Rotterdam Biologics B.V.
ATC code:
S01LA04
INN (International Name):
bevacizumab
Therapeutic group:
Oftalmológicos
Therapeutic area:
Degeneração macular úmida
Therapeutic indications:
Treatment of neovascular (wet) age-related macular degeneration (AMD).
Authorization status:
Recusou
